1 / 22

Presented By: Camille Frances Hanginan , M.D.

Oral Carnitine Supplementation Reduces Body Weight And Insulin Resistance In Women With Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial. Mansooreh Samimi , Mehri Jamilian , Faraneh Afshar Ebrahimi , Maryam Rahimi ‡, Banafsheh Tajbakhsh and Zatollah Asemi.

hestia
Download Presentation

Presented By: Camille Frances Hanginan , M.D.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Oral Carnitine Supplementation Reduces Body Weight And Insulin Resistance In Women With Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial MansoorehSamimi, MehriJamilian, FaranehAfsharEbrahimi, Maryam Rahimi‡, BanafshehTajbakhsh and ZatollahAsemi • Presented By: • Camille Frances Hanginan, M.D. SOURCE: Clinical Endocrinology (2016) 84, 851–857

  2. Introduction

  3. POLYCYSTIC OVARIAN SYNDROME • one of the most common endocrine disorders • can affect up to 10% of women around the world • Diagnosis: • anovulatorycycles or irregular periods • signs of hyperandrogenism • enlarged ovaries (> 10 cm3 ) and the presence of 10 or more peripherally oriented cystic structures (2 to 8 mm) surrounding a dense stroma. • Lentz, G., Lobo, R., Gershenson D., Katz, V., (2012). Comprehensive Gynecology. 6th edition

  4. POLYCYSTIC OVARIAN SYNDROME • 30-70% are overweight • Up to 70% have insulin resistance • Can lead to diabetes mellitus • Lentz, G., Lobo, R., Gershenson D., Katz, V., (2012). Comprehensive Gynecology. 6th edition

  5. POLYCYSTIC OVARIAN SYNDROME • Addressing metabolic and weight concerns • diet • exercise regimens • metformin • Lentz, G., Lobo, R., Gershenson D., Katz, V., (2012). Comprehensive Gynecology. 6th edition

  6. CARNITINE • endogenous compound that has a role in energy metabolism • transfers long-chain fatty acids to the mitochondria for subsequent beta oxidation in order to produce energy • can help lose weight • can help treat insulin resistance • Longo, N., Frigeni, M., & Pasquali, M. (2016). Carnitine transport and fatty acid oxidation. Biochimica et biophysicaacta, 1863(10), 2422–2435. doi:10.1016/j.bbamcr.2016.01.023

  7. Relevance

  8. RELEVANCE • A substantial amount of information on carnitine’s effects on glucose homeostasis and weight loss can readily be found. • The effect of this compound on women with PCOS, a condition highly associated with weight gain and insulin resistance has not yet been widely studied.

  9. Objectives

  10. OBJECTIVE • to determine the effects of oral supplementation of carnitine on weight loss, fasting blood sugar, insulin concentrations, lipid profiles, and androgen hormones on women with PCOS

  11. Highlights

  12. Study Design • A randomized, double-blind, placebo-controlled clinical trial to determine the effects of oral carnitine supplementation on weight loss and metabolic profiles of women with PCOS

  13. Sample Population • Eligible for the study: • Diagnosis of PCOS using the Rotterdam criteria • Aged 18-40 • those with a body mass index of >25kg/m2 with phenotypes A(oligo/anovulation + hyperandrogenism + polycystic ovary morphology) and D (oligo/anovulation + polycystic ovary morphology) • No hyperprolactinemia, DM, thyroid disease, not having a special diet or intake of a drug with a known effect on hormones, no intake of ovulation induction agents, and those not on anti-obesity therapies in the last 3 months prior to the start of the study

  14. Methodology & Intervention • Half of the 60 women included in the study received 250mg carnitine supplements for 12 weeks while the other half received placebo containing cellulose, also for 12 weeks. • Participants’ compliance was checked through counting of unused capsules.

  15. Methodology & Intervention • The variables assessed in the study: • the participants’ body weight, BMI, waist circumference, hip circumference(HC) • fasting plasma glucose(FPG), lipid profiles, serum insulin levels, and androgenic hormones. • Blood samples for the biochemical assessment were taken at the beginning and end of the study for which commercial kits and ELISA kit were used.

  16. Results • 12 weeks of carnitine supplementation was found to decrease FPG, serum insulin levels, as well as reduction in weight, BMI, and HC. • No significant changes on lipid profiles nor free testosterone

  17. Limitations of the Study • quantification of carnitine concentration was not done due to limited funding. • small sample size • the markers of inflammation, oxidative stress, and sex hormone-binding globulin were not assessed. • the reduction of FPG seen in the carnitine group may have been caused by regression to mean due to the 4g dose used in the study.

  18. Conclusion

  19. CONCLUSION • Among women with PCOS, carnitine can have beneficial effects on weight, BMI, WC, HC, FPG, and serum insulin levels. • It was not found to have influence on lipid profiles nor free testosterone. • A longer period of clinical trial with higher doses of carnitine supplementation are recommended to further establish its effect on insulin resistance, lipid concentrations, an hormonal outcomes.

  20. References • Lentz, G., Lobo, R., Gershenson D., Katz, V., (2012). Comprehensive Gynecology. 6th edition • Dunaif A, Xia J, Book CB, Schenker E, Tang Z., (1995).Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest.; 96(2):801-10. • Longo, N., Frigeni, M., & Pasquali, M. (2016). Carnitine transport and fatty acid oxidation. Biochimica et biophysicaacta, 1863(10), 2422–2435. doi:10.1016/j.bbamcr.2016.01.023 • Kalpana, Aruna, (2012). Effects of L-Carnitine (Neutraceutical) In Weight Management among Overweight and Obese Adults of Age between 20 – 45yrs – A Comparative Study in Chennai and Tirupathi. International Journal of Scientific and Research Publications, Volume 2, Issue 9 • Lopaschuk G, (2016). Fatty Acid Oxidation and Its Relation with Insulin Resistance and Associated Disorders. Ann NutrMetab; 68(suppl 3):15-20. doi: 10.1159/000448357

More Related